There is research on this stock available only to PRO subscribers.
From other sites
at Benzinga.com (Dec 30, 2014)
at MarketWatch.com (Sep 26, 2012)
SCMP vs. ETF Alternatives
Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company engaged in research, development & sale of proprietary drugs based on ion channel activators known as prostones to treat gastrointestinal, neurologic, & oncology-based inflammatory disorders.
Other News & PR